Nvidia Earnings Preview: Can AI Buyers Absorb Higher Costs?

Nvidia reports fiscal second-quarter results Wednesday, August 26, and the headline numbers are unlikely to be the hardest part of the setup. This Nvidia earnings preview comes as Wall Street expects roughly $92 billion in revenue, nearly double the year-ago level, with adjusted earnings around $2.09 per share as hyperscalers continue spending aggressively on AI infrastructure. Options markets are pricing roughly a 6% post-earnings move, while investors broadly expect another strong quarter and potentially another beat-and-raise.

The obvious debate is whether AI demand remains strong enough to support Blackwell growth, mid-70% gross margins and the coming Vera Rubin ramp. But a new variable has entered the equation at exactly the wrong—or right—time. Bloomberg reported over the weekend that some Nvidia-powered server configurations shipping in early 2027 could see prices rise by more than 15%, largely because of surging memory costs.

That changes the earnings question. The market may care less about what Nvidia sold this quarter than whether customers can absorb meaningfully higher AI infrastructure costs over the next two quarters without slowing deployment.

What Wall Street Is Modeling: Nvidia Earnings Preview

The base case is already demanding.

Consensus estimates point to revenue of roughly $92 billion, compared with Nvidia's prior-quarter guidance of $91 billion, plus or minus 2%. More bullish analysts are looking for something closer to $95 billion, while Jefferies has reportedly modeled approximately...

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Palo Alto Networks’ $4.5B AI Acquisition: What’s At Stake?

Palo Alto Networks (NASDAQ:PANW) is making another major move...

Freshworks Takeover Rumors: Who Could Buy It?

Freshworks Inc. (NASDAQ:FRSH) suddenly has a new question hanging...

Eli Lilly Acquisition: What Calytrix Bio Adds To Oncology

Eli Lilly and Company (NYSE:LLY) is making a move...

Diamondback Energy’s $5 Billion Double Eagle Acquisition Gamble

Diamondback Energy (NASDAQ:FANG) could be preparing another major move...

Tandem Diabetes Care: FDA Clears 7-Day Tubeless Pump

Tandem Diabetes Care (NASDAQ:TNDM) has secured an important regulatory...

Related Articles

Palo Alto Networks’ $4.5B AI Acquisition: What’s At Stake?

Palo Alto Networks (NASDAQ:PANW) is making another major move...

Freshworks Takeover Rumors: Who Could Buy It?

Freshworks Inc. (NASDAQ:FRSH) suddenly has a new question hanging...

Eli Lilly Acquisition: What Calytrix Bio Adds To Oncology

Eli Lilly and Company (NYSE:LLY) is making a move...

Diamondback Energy’s $5 Billion Double Eagle Acquisition Gamble

Diamondback Energy (NASDAQ:FANG) could be preparing another major move...

Tandem Diabetes Care: FDA Clears 7-Day Tubeless Pump

Tandem Diabetes Care (NASDAQ:TNDM) has secured an important regulatory...

CoreWeave Insider Selling: Why CEO Paused After $794 Million

CoreWeave (NASDAQ: CRWV) has given investors an unusual question...

Nvidia Jensen Scandal: Can Nvidia Survive Without Huang?

What happens when the man who helped build the...

Micron Stock Forecast: Could AI Fuel 148% Upside?

Micron Technology (NASDAQ: MU) has become one of Wall...
spot_img

Related Articles

Popular Categories

spot_imgspot_img